<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2172-1-1.anc" start="29450" end="29461" sStart="-1" offset="0" sid="null" wn="2" wnkey="transfer%2:40:01::" text="After a 10 min spin at 14,000 rpm in a microcentrifuge, the supernatants were &lt;b&gt;transferred&lt;/b&gt; to new tubes." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2172-1-1.anc" start="33018" end="33029" sStart="null" offset="0" sid="null" wn="3" wnkey="transfer%2:38:05::" text="Supernatants were &lt;b&gt;transferred&lt;/b&gt; to new tubes and nuclei were subsequently washed two times with 50 ?l of buffer A. Protein in the supernatant and pellet fractions were dissolved in SDS sample buffer, resolved by 8% SDS-PAGE, &lt;b&gt;transferred&lt;/b&gt; to nitrocellulose, and immunoblotted with anti-HA antibody." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2172-1-1.anc" start="33263" end="33274" sStart="null" offset="0" sid="null" wn="3" wnkey="transfer%2:38:05::" text="Supernatants were &lt;b&gt;transferred&lt;/b&gt; to new tubes and nuclei were subsequently washed two times with 50 ?l of buffer A. Protein in the supernatant and pellet fractions were dissolved in SDS sample buffer, resolved by 8% SDS-PAGE, &lt;b&gt;transferred&lt;/b&gt; to nitrocellulose, and immunoblotted with anti-HA antibody." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2172-1-1.anc" start="29450" end="29461" sStart="null" offset="0" sid="null" wn="2" wnkey="transfer%2:40:01::" text="After a 10 min spin at 14,000 rpm in a microcentrifuge, the supernatants were &lt;b&gt;transferred&lt;/b&gt; to new tubes." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2172-1-1.anc" start="29450" end="29461" sStart="null" offset="0" sid="null" wn="2" wnkey="transfer%2:40:01::" text="After a 10 min spin at 14,000 rpm in a microcentrifuge, the supernatants were &lt;b&gt;transferred&lt;/b&gt; to new tubes." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2172-1-1.anc" start="25548" end="25553" sStart="null" offset="0" sid="null" wn="1" wnkey="time%1:11:00::" text="The recombinant protein was purified on anti-HA-conjugated beads and washed two &lt;b&gt;times&lt;/b&gt; in TGEMD buffer (20 mM Tris (pH 7.9), 20% (v/v) glycerol, 1 mM EDTA, 5 mM MgCl 2 , 0.1% NP-40, 0.2 mM PMSF, 1 ?g/ml leupeptin, 1.4 ?g/ml pepstatin A, and 1 mM DTT) containing 1 M NaCl and an additional two &lt;b&gt;times&lt;/b&gt; in TGEMD buffer containing 0.2 M NaCl." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2172-1-1.anc" start="13739" end="13744" sStart="null" offset="0" sid="null" wn="4" wnkey="show%2:39:00::" text="As &lt;b&gt;shown&lt;/b&gt; in Figure 4C, GST-NFATp(1-921) activated transcription, while GST-NFATp(391-583) did not activate transcription." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-1-1.anc" start="10993" end="10997" sStart="null" offset="113" sid="r10.high.j.0789" wn="1" wnkey="high%3:00:02::" text="When NFATp was added to the reconstituted transcription system it activated transcription to high levels from the DNA template containing three high affinity NFAT sites (Figure 3D)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-1-1.anc" start="23828" end="23832" sStart="null" offset="174" sid="r10.high.j.0383" wn="1" wnkey="high%3:00:02::" text="p(NFAT) 3 -E1b-CAT, used as template DNA in the in vitro transcription assays, was created by inserting three direct copies of the murine IL-4 high affinity NFAT site (region -82 to -64 of the murine IL-4 promoter) into the Xba I site of plasmid E1b-CAT." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-1-1.anc" start="7828" end="7832" sStart="null" offset="147" sid="r10.high.j.0336" wn="1" wnkey="high%3:00:02::" text="In other studies we found the observed equilibrium dissociation constant ( obs K D ) of recombinant HA-NFATp for a high affinity NFAT site (mouse IL-4 promoter) to be 1 nM (data not shown)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-1-1.anc" start="27969" end="27973" sStart="null" offset="74" sid="r9.full.j.0500" wn="2" wnkey="full%5:00:01:whole:00" text="The expression and purification of recombinant human cJun/cFos (full length proteins) will be described elsewhere (H." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-1-1.anc" start="19204" end="19209" sStart="null" offset="151" sid="r10.find.v.0725" wn="4" wnkey="find%2:32:00::" text="Moreover, when HA-NFATp(331-722), which was not highly phosphorylated, was tested in the nuclei-association assay it was primarily found in the pellet with the nuclei, regardless of whether it was treated with calcineurin or not (data not shown)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-1-1.anc" start="3026" end="3032" sStart="null" offset="148" sid="r8.family.n.0516" wn="6" wnkey="family%1:14:03::" text="The C-terminal regions of NFAT proteins are unique in sequence and may be responsible for functional differences among NFAT family members." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2172-1-1.anc" start="4133" end="4137" sStart="null" offset="0" sid="null" wn="4" wnkey="date%1:28:02::" text="To &lt;b&gt;date&lt;/b&gt;, biochemical analysis of NFATp and other NFAT members has been conducted using only portions and not the full-length versions of these proteins." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-1-1.anc" start="32726" end="32733" sStart="null" offset="97" sid="r10.control.n.0612" wn="4" wnkey="control%1:09:02::" text="For each binding reaction, 5 ?l of NFATp dephosphorylation reaction (or a mock treated control reaction) was added to 10 ?l of nuclei slurry and allowed to incubate with gentle mixing for 10 min at room temperature." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-1-1.anc" start="16067" end="16078" sStart="null" offset="65" sid="r11.combination.n.0872" wn="1" wnkey="combination%1:14:00::" text="After purification we treated the four proteins with a combination of calcineurin and calmodulin to remove phosphates attached to serines and threonines on the recombinant proteins." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-1-1.anc" start="18039" end="18044" sStart="null" offset="100" sid="r8.ask.v.0723" wn="2" wnkey="ask%2:32:02::" text="Upon discovering that recombinant HA-NFATp was phosphorylated in its N-terminal region we asked if the phosphorylation state of HA-NFATp would influence its ability to associate with nuclei in an in vitro assay." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2172-1-1.anc" start="7451" end="7456" sStart="null" offset="0" sid="null" wn="1" wnkey="add%2:30:00::" text="When increasing amounts of HA-NFATp were &lt;b&gt;added&lt;/b&gt; to IL-2 DNA in the absence of cJun/cFos, the -45 NFAT site was protected from DNase I digestion, but as expected DNase I digestion of the composite element was unaffected (Figure 2, lanes 1-5)." />
  </sentences>
</list>